WebMar 31, 2024 · Since its inception in 2024, GenFleet has built up industry-leading capabilities and expertise in developing novel drug candidates - both small molecules and biologics. Its pipeline includes over 10 programs in development, four of … WebGenFleet Therapeutics to Present Phase I Data for GFH312 at 2024 American Society for Clinical Pharmacology & Therapeutics Meeting The data of cerebrospinal fluid (CSF) analysis from subjects receiving 120 mg daily administration suggest that GFH312 has exposure in the CNS and may potentially be useful for treating neurological indications.
ANZCTR - Registration
WebNov 9, 2024 · GenFleet Therapeutics (Australia) Pty Ltd. (1) Zhejiang Genfleet Therapeutics Co., Ltd. (1) Collaborator Intervention gfh312 (2) placebo (2) Study Documents Intervention Type drug (2) other (1) Funder Type Industry (2) Study Type Interventional (2) gfh312 Showing 1 - 2 of 2 Trials per page: STUDY CONDITIONS … WebJul 20, 2024 · About GenFleet Therapeutics Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and ... highways agency contact numbers
GenFleet Therapeutics LinkedIn
WebScientific title A First-in-human, Randomized, Double-blinded, Placebo- Controlled, Two-part Study to Assess Safety/Tolerability and Pharmacokinetics of Single- and Multiple-ascending Doses and Food Effect of GFH312 in Healthy Subjects Secondary ID [1] GFH312X3101 Universal Trial Number (UTN) Trial acronym Linked study record Health condition WebDec 31, 2024 · GenFleet Therapeutics, a clinical-stage biotechnology company with a focus in cutting-edge therapies in oncology and immunology, today announced the completion of $75 million (~500 million RMB) series C financing. WebDec 31, 2024 · SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company with a focus in cutting-edge therapies in oncology and immunology, today announced the... small tours on motorcoach from raleigh